AP
Anebulo Pharmaceuticals Inc
🇩🇪XFRA.214GermanyHealthcare
€0.75EURunchanged 0.00 (0%)ClosedEnd of day9:48 PM
Price€0.750.00 (0%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US0345691036
- CUSIP
- Not reported
Company
- Employees
- 2
- Headquarters
- Lakeway, United States
- Website
- https://www.anebulo.com
- CEO
- Mr. Richard Anthony Cunningham
Market
- Shares outstanding
- 40.8M
- Market cap
- €30.81M
Highlights
No high and low reported for today's session.
- Market cap
- €30.81M
- EPS LTM
- -$0.19
- P/E LTM
- -5.20
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$7.98M-4.06%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$5.84M+12.12%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.